Squarepoint
MED icon

Squarepoint’s Medifast MED Stock Holding History

Squarepoint’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,000
Closed -$672K – 4354
2023
Q4 		$672K Buy
+10,000
New +$697K ﹤0.01% 2802

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Squarepoint's MED Position: Q2 2026 in Review

Squarepoint opened a new position in Medifast (MED) in Q2 2026: 20,140 shares worth $214K. The stake represents ﹤0.01% of the portfolio and ranks #4028 among its holdings. This is a return to the name: Squarepoint previously reported a position in MED as recently as Q2 2024.

Squarepoint first reported a position in MED in Q4 2016 and has held it in 24 quarters since. The position peaked at $9.51M in Q1 2019. 112 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • Squarepoint held 20,140 shares of Medifast worth $214K as of Q2 2026.
  • Medifast was a new Squarepoint position in Q2 2026.
  • Medifast made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #4028 holding.
  • Squarepoint first reported a position in Medifast in Q4 2016 and has held it in 24 quarters since.
  • Squarepoint's Medifast position peaked at $9.51M in Q1 2019.
  • 112 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.